Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Exp Immunol ; 162(2): 372-8, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20840653

ABSTRACT

Infection with Chlamydia pneumoniae (Cp) accounts for around 10% of community acquired bacterial pneumonia and has been associated with other chronic inflammatory conditions. We describe a C57/Bl6 murine model of Cp lung infection characterized by a dose-dependent, resolving neutrophilia followed by lymphocytic infiltration of the lungs. By 21 days post-infection, mice exhibit a T helper type 1 (Th1) polarized serum antibody response with local mucosal antibody secretion and organization of ectopic lymphoid tissue which persisted in the absence of detectable Cp DNA. Macrophage inflammatory protein (MIP)-2/CXCL2, which recruits neutrophils and lymphocytes and is associated with ectopic lymphoid tissue formation, was secreted in the lungs post-infection. In vitro, lung epithelial cells up-regulated MIP-2/CXCL2 in response to both rough lipopolysaccharide (reLPS) and Cp infection. We conclude that Cp infection can have long-term inflammatory effects on tissue that persist after clearance of active infection.


Subject(s)
Chemokine CXCL2/metabolism , Chlamydophila Infections/pathology , Chlamydophila pneumoniae , Choristoma/pathology , Lung/pathology , Lymphoid Tissue/pathology , Respiratory Mucosa/metabolism , Animals , Bronchoalveolar Lavage Fluid/chemistry , Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage Fluid/immunology , Cell Line , Chemokine CXCL2/genetics , Chlamydophila Infections/metabolism , Chlamydophila Infections/microbiology , Choristoma/immunology , DNA, Bacterial/metabolism , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Gene Expression/drug effects , Gene Expression/genetics , Immunoglobulin A/immunology , Immunoglobulin A/metabolism , Immunoglobulin G/blood , Immunoglobulin G/immunology , Inflammation/pathology , Lipopolysaccharides/immunology , Lipopolysaccharides/pharmacology , Lung/metabolism , Lung/microbiology , Lymphocytes/pathology , Lymphoid Tissue/immunology , Mice , Mice, Inbred C57BL , Neutrophils/pathology , Respiratory Mucosa/pathology , Time Factors
2.
Clin Exp Allergy ; 39(5): 731-9, 2009 May.
Article in English | MEDLINE | ID: mdl-19178536

ABSTRACT

BACKGROUND: Dietary fat intake has been associated with obesity and obesity in its turn with attenuated airway function and asthma, but it is unclear whether or how high-fat intake per se alters immune function relevant to development of allergic asthma. OBJECTIVE: To use a non-obese mouse model of mild to moderate allergic asthma to compare effects of high-fat with isocaloric control-diet on allergic immune responses. METHODS: C57BL/6 mice weaned and maintained on control (11% fat calories) or isocaloric high-fat diet (58% fat calories) were systemically sensitized with ovalbumin and challenged in the lungs. Allergic airway inflammation was assessed by measuring lung inflammation; serum antibodies; and, cytokines in serum, bronchoalveolar lavage (BAL) fluid and in supernatants of in vitro stimulated lung draining lymph node and spleen lymphocytes. RESULTS: There was a significant reduction in lung eosinophilia and IL-5 in high-fat fed mice. Lung draining lymph node cells from these mice showed reduced pro-inflammatory cytokine (MCP-1 and TNF-alpha) release after ovalbumin re-stimulation and reduced release of IL-13 after concanavalin-A stimulation, indicating a general rather than just an antigen-specific change. There was no difference in IFN-gamma release. In contrast, pro-inflammatory cytokine release was increased from splenocytes. Decreased eosinophilia was not due to increased regulatory T cell or IL-10 induction in draining lymph nodes or spleen, nor to changes in antibody response to ovalbumin. However, decreased levels of serum and BAL eotaxin were found in high-fat fed animals. CONCLUSIONS: The data indicate that high-fat dietary content redirects local immune responses to allergen in the lungs and systemic responses in the spleen and serum. These effects are not due to changes in regulatory T cell populations but may reflect a failure to mobilize eosinophils in response to allergic challenge.


Subject(s)
Asthma/immunology , Cytokines/immunology , Dietary Fats/adverse effects , Pneumonia/immunology , Pulmonary Eosinophilia/immunology , Animals , Asthma/etiology , Bronchoalveolar Lavage Fluid/immunology , Cells, Cultured , Concanavalin A/pharmacology , Dietary Fats/immunology , Disease Models, Animal , Lung/drug effects , Lung/immunology , Lung/pathology , Lymph Nodes/drug effects , Lymph Nodes/immunology , Lymph Nodes/metabolism , Mice , Mice, Inbred C57BL , Mice, Inbred NOD , Ovalbumin/immunology , Pneumonia/etiology , Pulmonary Eosinophilia/etiology , T-Lymphocytes, Regulatory/drug effects , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/metabolism
3.
Biochem Soc Trans ; 34(Pt 2): 279-82, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16545094

ABSTRACT

Recent evidence shows that human neutrophil elastase inhibitors can be synthesized locally at mucosal sites. In addition to efficiently targeting bacterial and host enzymes, they can be released in the interstitium and in the lumen of mucosa, where they have been shown to have antimicrobial activities, and to activate innate immune responses. This review will address more particularly the pleiotropic functions of low-molecular-mass neutrophil elastase inhibitors [SLPI (secretory leucocyte proteinase inhibitor) and elafin] and, more specifically, their role in the development of the adaptive immune response.


Subject(s)
Immunity, Innate/immunology , Immunity/immunology , Proteins/immunology , Animals , Humans , Leukocyte Elastase/antagonists & inhibitors , Leukocyte Elastase/metabolism , Protease Inhibitors/metabolism , Protease Inhibitors/pharmacology , Proteinase Inhibitory Proteins, Secretory , Proteins/genetics , Proteins/metabolism , Proteins/therapeutic use , Secretory Leukocyte Peptidase Inhibitor
SELECTION OF CITATIONS
SEARCH DETAIL
...